Article
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
5 Aug 2020
Abstract excerpt
Genomic analysis revealed that EP300 is highly enriched at enhancers associated with genes involved in multiple profibrotic pathways, and broad transcriptomic and proteomic profiling of CREBBP/EP300 inhibition by the chemical probe SGC-CBP30 identified collagen VI (Col VI) as a prominent downstream regulator of myofibroblast activity. Targeted Col VI knockdown results in significant decrease in profibrotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
